VetSheet

催產素

Oxytocin

alpha-hypophamine

荷爾蒙製劑IMIVSCIntranasal小型哺乳類爬蟲類山羊

別名: Pitocin · Syntocinon · alpha-hypophamine · oxytocinum

由 VetSheet 獸醫團隊審訂更新於 2026年4月5日本內容以實證獸醫文獻為本

0.5-3 Units SC or IM every 30-60 minutes, best based upon the results of tokodynamometry.SC/IM· q30-60m· Until parturition is complete
0.5–3 unit 每隻動物的固定劑量(不按體重換算)

劑量為持牌獸醫專業人員的臨床參考。請務必對照最新藥品說明書及個別病患確認。

各物種劑量

🌎 NA — North America🌍 EU — Europe

適應症劑量途徑頻次療程地區
To augment uterine contractions during parturition0.5-3 Units SC or IM every 30-60 minutes, best based upon the results of tokodynamometry.SC/IMq30-60mUntil parturition is complete🌎 NA
For uterine inertia (if no fetuses in birth canal, cervix dilated, obstruction ruled out)5-20 Units (depending on size of animal) IM or as an IV drip (10 Units/liter) beginning as a slow drip and gradually increasing until effective contractions are observed. If no response to IM injection in 30 minutes, may repeat along with 10% dextrose IV slowly. If no response again in 30 minutes, repeat IM again.IM/IVAs directed🌎 NA
For uterine inertia (mini-dose protocol)0.25 Units (total dose) SC or IM to a maximum dose of 4 Units per bitch. Generally not given more frequently than hourly.SC/IMq1h🌎 NA
To induce milk let-down (adequate milk production, tolerates nursing)Oxytocin nasal spray: 5-10 minutes prior to nursing three times dailyIntranasalTID🌎 NA
For secondary agalactia0.25-1 Unit (total dose) SC q2h.SCq2h🌎 NA
For adjunctive treatment of acute metritis0.5-5 Units (total dose) IMIMOnce🌎 NA
To promote uterine involution after uterine prolapse manual reduction0.5-5 Units IM (Traas & O'Conner 2009) OR 5-10 Units (total dose) IM (Shaw 2007)IMOnce🌎 NA
  • For uterine inertia (if no fetuses in birth canal, cervix dilated, obstruction ruled out): Some texts recommend giving calcium gluconate (2-10 mL slowly IV) prior. If no response, perform C-section.
  • For uterine inertia (mini-dose protocol): Given 15 minutes after calcium gluconate 10% (1 mL/5.5 kg SC). Higher doses can cause tetanic contractions.
  • For secondary agalactia: Remove neonates for 30 mins post-injection. Often used with metoclopramide 0.1-0.2 mg/kg SC q12h.
  • For adjunctive treatment of acute metritis: May be used if birth occurred less than 24 hours prior.
  • To promote uterine involution after uterine prolapse manual reduction: Given following successful manual reduction.

適應症劑量途徑頻次療程地區
To promote uterine involution after uterine prolapse manual reduction0.5-5 Units IM OR 5-10 Units (total dose) IMIMOnce🌎 NA
To treat primary uterine inertia0.25 Units (total dose) SC or IM to a maximum dose of 4 Units per queen. Generally not given more frequently than hourly.SC/IMq1h🌎 NA
For adjunctive treatment of metritis0.5-5 Units IMIMOnce🌎 NA
To induce milk let-down (secondary agalactia)0.25-1 Unit (total dose) SC q2h.SCq2h🌎 NA
  • To promote uterine involution after uterine prolapse manual reduction: Extrapolated from dog doses.
  • To treat primary uterine inertia: Given 15 minutes after calcium gluconate.
  • For adjunctive treatment of metritis: May be used if birth occurred less than 24 hours prior.
  • To induce milk let-down (secondary agalactia): Remove neonates for 30 mins post-injection. Often used with metoclopramide.

小型哺乳類

適應症劑量途徑頻次療程地區
Uterotonic / Obstetrical use (Mice, Rats, Gerbils, Hamsters, Guinea pigs, Chinchillas)0.2-3 Units/kg IV, IM or SCIV/IM/SCOnce🌎 NA

適應症劑量途徑頻次療程地區
As a uterotonic agent0.5 Units/kg IM; may repeat in 60 minutesIMMay repeat in 60m🌎 NA
For egg expulsion0.01-0.1 mL once IM.IMOnce🌎 NA
  • For egg expulsion: Should be administered with Vitamin A and calcium (injectable).

爬蟲類

適應症劑量途徑頻次療程地區
For egg binding1-10 Units/kg IM.IMAs needed🌎 NA
To induce oviposition1-30 Units/kg (10 Units/kg appears effective in many chelonians). May have to repeat in several hours.IMMay repeat in several hours🌎 NA
  • For egg binding: Given in combination with calcium glubionate. Use care with multiple injections. Not as effective in lizards.
  • To induce oviposition: Risk of oviduct rupture if cloaca is obstructed.

適應症劑量途徑頻次療程地區
To augment or initiate uterine contractions during parturition in properly evaluated mares2.5-5 Units IV, every 15-20 minutes until foal is bornIVq15-20mUntil foal is born🌎 NA
To prevent luteolysis (prolong corpus luteum lifespan)60 Units (3 ml) IM once daily from day 7 to day 14 post-ovulation.IMq24hDays 7 to 14 post-ovulation🌎 NA
For evacuation of uterine fluid20 Units IV or IM one to three times a dayIV/IMSID to TID🌎 NA
To aid in removal of retained fetal membranes30-100 Units in 1 liter of normal saline IV over 30-60 minutes OR 10-120 Units IM OR 10-40 Units by IV bolusIV/IMOnce🌎 NA
To aid in removal of retained fetal membranes (alternative)20 Units IV or IM given every hour beginning 2-3 hours after foaling. Repeat as needed.IV/IMq1hAs needed🌎 NA
For mild to moderate cases of acute post-partum metritis20 Units IM 3-4 times a day for 2-3 daysIMTID to QID2-3 days🌎 NA
To treat esophageal obstruction ('choke')0.11-0.22 Units/kg IV onceIVOnce🌎 NA
  • To prevent luteolysis (prolong corpus luteum lifespan): Ovulation must be documented closely.
  • To aid in removal of retained fetal membranes: Large dose IV boluses are not recommended as they may cause uterine spasm and abdominal discomfort.
  • To treat esophageal obstruction ('choke'): Given with N-butylscopolammonium bromide. Avoid or reduce dose in mares. Do not use in pregnant mares.

適應症劑量途徑頻次療程地區
For retained placenta40-60 Units oxytocin q2h as necessary.IM/IVq2hAs necessary🌎 NA
To reduce incidence of retained placenta20 Units IM immediately following calving and repeated 2-4 hours laterIMOnce, then repeat in 2-4h🌎 NA
For mild to moderate cases of acute post-partum metritis20 Units IM 3-4 times a day for 2-3 daysIMTID to QID2-3 days🌎 NA
To augment uterine contractions during parturition30 Units IM; repeat no sooner than 30 minutes if necessaryIMq30mAs necessary🌎 NA
For obstetrical use in cows100 Units IV, IM or SCIV/IM/SCOnce🌎 NA
For milk let-down in cows10-20 Units IVIVOnce🌎 NA
  • For retained placenta: Often used with IV calcium. Limited value after 48 hours postpartum.

適應症劑量途徑頻次療程地區
For adjunctive treatment of agalactia syndrome (MMA) in sows30-40 Units per sow at 3-4 hoursIM/IVq3-4h🌎 NA
For adjunctive treatment of agalactia syndrome (MMA) in sows (alternative)20-50 Units IM or 5-10 Units IVIM/IVOnce🌎 NA
For retained placenta in patients with uterine atony20-30 Units oxytocin q2-3h as necessaryIM/IVq2-3hAs necessary🌎 NA
To augment uterine contractions during parturition10 Units IM; repeat no sooner than 30 minutes if necessaryIMq30mAs necessary🌎 NA
For obstetrical use in sows30-50 Units IV, IM or SCIV/IM/SCOnce🌎 NA
For mild to moderate cases of acute post-partum metritis5-10 Units IM 3-4 times a day for 2-3 daysIMTID to QID2-3 days🌎 NA
For mild to moderate cases of acute post-partum metritis (alternative)5 Units IM; may need to be repeated as effect may be as short as 30 minutesIMAs needed🌎 NA
For milk let-down in sows5-20 Units IVIVOnce🌎 NA
  • For retained placenta in patients with uterine atony: Use with broad-spectrum antibiotics.

適應症劑量途徑頻次療程地區
For retained placenta in patients with uterine atony10-20 Units oxytocin.IM/IVOnce🌎 NA
For mild to moderate cases of acute post-partum metritis5-10 Units IM 3-4 times a day for 2-3 daysIMTID to QID2-3 days🌎 NA
  • For retained placenta in patients with uterine atony: Limited value after 48 hours postpartum. Note for CAMELIDS (NW): 5-10 Units IM at 10-minute intervals for retained placenta (Adams 2008).

山羊

適應症劑量途徑頻次療程地區
For retained placenta in patients with uterine atony10-20 Units oxytocin.IM/IVOnce🌎 NA
For mild to moderate cases of acute post-partum metritis5-10 Units IM 3-4 times a day for 2-3 daysIMTID to QID2-3 days🌎 NA
To control post-extraction cervical and uterine bleeding after internal manipulations10-20 Units IV, may repeat SC in 2 hoursIV/SCOnce, may repeat in 2h🌎 NA
  • For retained placenta in patients with uterine atony: Limited value after 48 hours postpartum.

劑量為持牌獸醫專業人員的臨床參考。請務必對照最新藥品說明書及個別病患確認。

正在為病患診症?VetSheet 的 AI 會把藥物、劑量與療程直接寫入結構化診症筆記。了解 VetSheet 如何運作

概覽

催產素是一種由下丘腦室旁核和視上核合成,並儲存於垂體後葉的九肽激素。在獸醫學中,它主要作為子宮收縮劑,用於引產或增強分娩時的子宮收縮、治療產後胎盤滯留和子宮內膜炎、促進子宮復舊,以及在無乳症情況下促進排乳。

​臨床要點:​

  • ​偏好微量給藥 (Mini-dosing):​ 現代獸醫產科學強烈建議使用「微量劑量」(例如狗的總劑量為 0.25-4 單位),而非傳統的高劑量。高劑量會導致強直性、無效的子宮收縮,透過壓迫胎盤損害胎兒氧氣供應,並增加子宮破裂的風險。
  • ​鈣依賴性:​ 催產素的功效高度依賴細胞外鈣離子。給藥前必須糾正低血鈣或低血糖。鈣能增加收縮的「強度」,而催產素增加的是「頻率」。
  • ​子宮頸狀態:​ 如果子宮頸未開或存在未經矯正的阻塞性難產,絕對不可使用催產素。

作用機制

Oxytocin exerts its effects by binding to specific ​G-protein coupled oxytocin receptors (OXTR)​ on the cell membrane of uterine myofibrils and myoepithelial cells of the mammary gland.

  • ​Uterine Contraction:​ Binding to OXTR activates the Gq/11 pathway → stimulates ​Phospholipase C (PLC)​ → increases inositol triphosphate (IP3) and diacylglycerol (DAG) → triggers the release of intracellular calcium from the sarcoplasmic reticulum. Calcium binds to calmodulin, activating ​Myosin Light Chain Kinase (MLCK)​, leading to smooth muscle contraction. The threshold for oxytocin-induced contraction is significantly lowered late in pregnancy due to upregulation of oxytocin receptors by high estrogen levels.
  • ​Milk Let-down:​ Oxytocin stimulates the contraction of myoepithelial cells surrounding the mammary alveoli, forcing milk into the larger ducts and cisterns. It does not have galactopoietic (milk-producing) properties.

安全性與警告

禁忌症

  • Dystocia due to abnormal fetal presentation (unless corrected)
  • Closed or unrelaxed cervix
  • Known hypersensitivity to oxytocin
  • Significant cephalopelvic disproportion
  • Obstetrical emergencies where surgical intervention (C-section) is warranted
  • Pregnancy (for nasally administered oxytocin)

不良反應

  • Uterine cramping and discomfort
  • Tetanic uterine contractions (at high doses)
  • Uterine rupture
  • Fetal compromise or death (due to placental compression)
  • Water intoxication (with prolonged high-dose infusions)
  • Hypersensitivity reactions (more common with non-synthetic products)

注意事項

​Critical Warning:​ Always evaluate the patient for obstructive dystocia and ensure the cervix is dilated before administration.

  • ​Metabolic Status:​ Treat hypoglycemia or hypocalcemia before using oxytocin, as uterine fatigue is often secondary to these metabolic deficits.
  • ​Water Intoxication:​ While oxytocin has minimal antidiuretic properties, water intoxication can occur if administered at too rapid a rate or if excessively large volumes of electrolyte-free IV fluids are given concurrently. Signs include depression, coma, and seizures.
  • ​Fetal Monitoring:​ Monitor fetal heart rates if possible, as excessive uterine contractions can cause fetal hypoxia.

藥物相互作用

Thiopental

May delay thiopental anesthesia (reported in humans; clinical significance in animals is not firmly established).

Vasoconstrictors (Sympathomimetics)

Concurrent use post-partum may result in severe hypertension. Monitor closely.

監測

  • Uterine contractions (frequency, duration, and strength via tokodynamometry if available)
  • Status of the cervix (must be dilated)
  • Fetal monitoring (heart rate/distress)
  • Maternal calcium and glucose levels

藥物動力學

吸收

Destroyed in the GI tract; must be administered parenterally. Intranasal absorption can be erratic. Uterine response is almost immediate after IV administration, and within 3-5 minutes following IM administration.

分佈

Distributed throughout the extracellular fluid. Small quantities cross the placenta and enter the fetal circulation.

代謝

Metabolized rapidly in the liver and kidneys. A circulating enzyme, oxytocinase, can also destroy the hormone.

排除

Very small amounts are excreted unchanged in the urine. Duration of effect in dogs is ~13 minutes (IV) and ~20 minutes (IM/SC).

過量

Effects of overdosage on the uterus depend on the stage of the uterus and the position of the fetus(es).

  • ​Uterine Effects:​ Hypertonic or tetanic contractions can occur, leading to tumultuous labor, uterine rupture, fetal injury, or fetal death due to compromised placental blood flow.
  • ​Water Intoxication:​ Can occur if large doses are infused for a long period, especially with large volumes of electrolyte-free IV fluids.
    • Early signs: Listlessness, depression.
    • Severe signs: Coma, seizures, death.
    • Treatment: Stop oxytocin therapy, restrict water access. Severe cases may require osmotic diuretics (mannitol, urea, dextrose) with or without furosemide.

可用產品

劑型

  • Injection (solution)
  • Nasal spray

獸醫用

  • Oxytocin for Injection: 20 USP Units/mL in 10 mL, 30 mL, and 100 mL vials

人用標示

  • Oxytocin Solution for Injection: 10 Units/mL in 1 mL amps, 3 mL & 10 mL vials and 10 mL multiple-dose vials (Pitocin®)

各地核准狀態

暫無法規資料: 🇺🇸 US · 🇪🇺 EU · 🇬🇧 UK · 🇭🇰 HK · 🇹🇼 TW · 🇯🇵 JP · 🇰🇷 KR · 🇦🇺 AU

儲存與穩定性

Store at temperatures less than 25°C (77°F); do not freeze. Some manufacturers recommend refrigeration (2-8°C), but some products are stable for up to 5 years if stored at less than 26°C.

飼主須知

催產素是一種強效荷爾蒙,用於幫助您的寵物分娩或促進排乳。

  • ​需要專業監測:​ 僅應在能夠充分監測其作用的獸醫師直接指導或給藥下使用。
  • ​誤用風險:​ 在胎兒卡住或產道未完全打開時給予催產素,可能會導致嚴重的併發症,包括子宮破裂和未出生胎兒的死亡。
  • ​鼻腔噴霧劑:​ 如果為您開立了用於促進排乳的鼻腔噴霧劑,請完全按照指示給藥,通常在哺乳前 5-10 分鐘使用。

VetSheet 藥物參考供持牌獸醫專業人員作臨床決策輔助之用,不能取代專業判斷或廠方最新藥品說明書。